Sumeet Mody

Stock Analyst at Piper Sandler

(3.63)
# 239
Out of 5,234 analysts
54
Total ratings
80.00%
Success rate
47.13%
Average return
13 Stocks
Name Action Price Target Current % Upside Ratings Updated
Enfusion
Maintains: Neutral
10 12
10.43 10.26% 4 Dec 23, 2024
SEI Inv
Maintains: Neutral
58 66
81.9 -19.41% 4 Dec 20, 2023
GCM Grosvenor
Maintains: Overweight
9 10
12.55 -20.32% 2 Aug 10, 2023
KKR & Co
Maintains: Overweight
59 70
150.85 -53.6% 4 Aug 8, 2023
Blackstone
Maintains: Overweight
107 115
174.73 -34.18% 7 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 13
8.27 57.19% 1 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
17 15
23.5 -36.17% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
35 38
63.41 -40.07% 6 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
248 260
216.81 19.92% 11 Mar 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 23
18.24 26.1% 5 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 97
180.37 -46.22% 2 Feb 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 48
52.7 -8.92% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
55 58
n/a n/a 4 May 2, 2022